Sign In
Last checked at 
24 Sep 2021 13:05
Ā
Ā
FORMĀ 8.3
Ā
IRISHĀ TAKEOVERĀ PANEL
Ā
DISCLOSUREĀ UNDERĀ RULEĀ 8.3Ā OFĀ THEĀ IRISHĀ TAKEOVERĀ PANEL ACT,Ā 1997,Ā TAKEOVERĀ RULES,Ā 2013
Ā
DEALINGSĀ BYĀ PERSONSĀ WITHĀ INTERESTSĀ INĀ RELEVANTĀ SECURITIESĀ REPRESENTINGĀ 1%Ā ORĀ MORE
Ā
1. KEYĀ INFORMATION
Ā
Name of person dealing (Note 1) | Ā Lazard Asset Management Ltd |
Company dealt in | Ā XERIS PHARMACEUTICALS INC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | Ā Ordinary shares |
Date of dealing | Ā 23 September 2021 |
Ā
2. INTERESTSĀ ANDĀ SHORTĀ POSITIONS
Ā
(a) InterestsĀ andĀ shortĀ positionsĀ (followingĀ dealing)Ā inĀ theĀ classĀ ofĀ relevantĀ securityĀ dealtĀ inĀ (NoteĀ 3)
Ā | Long | Short | ||||
Ā | Number | Ā | (%) | Number | Ā | (%) |
(1) Relevant securities | Ā 173,388 0.260% | 2,608,133 3.923% | ||||
(2) Derivatives (other than options) | Ā | Ā | ||||
(3) Options and agreements to purchase/sell | Ā | Ā | ||||
Total | Ā 173,388 0.260% | 2,608,133 3.923% | ||||
| Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
(b) InterestsĀ andĀ shortĀ positionsĀ inĀ relevantĀ securitiesĀ ofĀ theĀ company,Ā otherĀ thanĀ theĀ classĀ dealtĀ inĀ (NoteĀ 3)
Class of relevant security: | Long | Short | ||||
Ā | Number | Ā | (%) | Number | Ā | (%) |
(1) Relevant securities | Ā | Ā | ||||
Ā (2) Derivatives (other than options) | Ā | Ā | ||||
Ā (3) Options and agreements to purchase/sell | Ā | Ā | ||||
Total | Ā | Ā | ||||
| Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
Ā
Ā
1. DEALINGSĀ (NoteĀ 4)
Ā
(a) PurchasesĀ andĀ sales
Ā
Ā Purchase/sale | Ā Number of relevant securities | Ā Price per unit (Note 5) |
Sell | 4063 | USD 2.5601 |
Ā
Ā
Ā
(b) DerivativesĀ transactionsĀ (otherĀ thanĀ optionsĀ transactions)
Ā
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
CFD | Short Sell | 9051 | USD 2.5601 Ā Ā |
Ā
Ā
(c) OptionsĀ transactionsĀ inĀ respectĀ ofĀ existingĀ relevantĀ securities
Ā
Ā
(i) Writing,Ā selling,Ā purchasingĀ orĀ varying
Ā
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
Ā | Ā | Ā | Ā | Ā | Ā | Ā |
Ā
Ā
Ā
(ii) Exercising
Ā
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
Ā | Ā | Ā |
Ā
Ā
(d) OtherĀ dealingsĀ (includingĀ transactionsĀ inĀ respectĀ ofĀ newĀ securities)Ā (NoteĀ 4)
Ā
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
Ā | Ā | Ā |
Ā
Ā
Ā
2. OTHERĀ INFORMATION
Ā
Agreements,Ā arrangementsĀ orĀ understandingsĀ relatingĀ toĀ optionsĀ orĀ derivatives
Ā
Ā
Ā
Ā
FullĀ detailsĀ ofĀ anyĀ agreement,Ā arrangementĀ orĀ understandingĀ betweenĀ theĀ personĀ disclosing andĀ
anyĀ otherĀ personĀ relatingĀ toĀ theĀ votingĀ rightsĀ ofĀ anyĀ relevantĀ securitiesĀ underĀ anyĀ option referredĀ toĀ
onĀ thisĀ formĀ orĀ relatingĀ toĀ theĀ votingĀ rightsĀ orĀ futureĀ acquisitionĀ orĀ disposalĀ ofĀ anyĀ relevantĀ securitiesĀ toĀ
whichĀ anyĀ derivativeĀ referredĀ toĀ onĀ thisĀ formĀ isĀ referenced.Ā IfĀ none,Ā this shouldĀ beĀ stated.
Ā
Ā
Ā
Ā
Ā
Ā
Ā
Ā
Ā
Ā
IsĀ aĀ SupplementalĀ FormĀ 8Ā attached?Ā (NoteĀ 9) Ā NO
Ā
Date of disclosure | 24 September 2021 |
Contact name | Harrison Leney |
Telephone number | 020 7448 2335 |
If a connected EFM, name of offeree/offeror with which connected | Ā |
If a connected EFM, state nature of connection (Note 10) | Ā |
Ā
Ā
Follow the stocks
